If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Share News (GWP)

  • There is currently no data for GWP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3 Aug 2015 15:21

Earnings, Trading Statements Calendar - Week Ahead

Read more
3 Aug 2015 05:19

Earnings, Trading Statements Calendar - Week Ahead

Read more
31 Jul 2015 15:25

Earnings, Trading Statements Calendar - Week Ahead

Read more
31 Jul 2015 05:18

Earnings, Trading Statements Calendar - Week Ahead

Read more
30 Jul 2015 15:15

Earnings, Trading Statements Calendar - Week Ahead

Read more
11 Jun 2015 12:57

GW Pharmaceuticals starts second Epidiolex drug trial

GW Pharmaceuticals said on Thursday that it has started the second of two Phase 3 trials of Epidiolex, which is used for the treatment of Lennox-Gastaut syndrome (LGS). In 2014, GW received orphan drug designation from the US Food and Drug Administration for Epidiolex for the treatment of LGS and it

Read more
11 Jun 2015 11:13

GW Pharmaceuticals Starts Second Epidiolex Trial For Lennox-Gastaut

Read more
15 May 2015 16:48

GW Pharmaceuticals Raises Additional USD25.3M In Offering (ALLISS)

Read more
11 May 2015 11:28

GW Pharmaceuticals Starts Phase III Trial, First Half Loss Widens

Read more
11 May 2015 06:01

LONDON MARKET COMMENT: Stocks Seen Lower Ahead Of BoE, Eurogroup

Read more
8 May 2015 16:15

LONDON MARKET CLOSE: Stocks Enjoy Relief Rally As Conservatives Win

Read more
6 May 2015 11:12

GW Pharmaceuticals Begins Phase 2 Epilepsy Research Study

Read more
6 May 2015 07:42

GW Pharmaceuticals Raises USD179.2 Million In Offering (ALLISS)

Read more
29 Apr 2015 08:16

GW Pharmaceuticals To Raise USD179.2 Million In US Share Issue (ALLISS)

Read more
28 Apr 2015 12:06

GW Pharmaceuticals to tap US investors for cash

London-based bio-pharmaceutical company GW Pharmaceuticals announced it will go cap in hand to investors in the US, although the exact terms of the share issue will depend on market conditions. On Tuesday, the company said its plans to sell 1.25m American Depositary Shares (ADSs) on the NASDAQ G

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.